AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
COTY

Coty Inc. Class A Common Stock (COTY) fair value

Consumer Defensive · Household & Personal Products · NYSE · United States
$3.23+0.62%
Market cap $2.8BNext earnings 2026-11-04Updated Oct 21, 2026
Add earnings to calendarGoogle
Our verdict
Trades 32% below our fair value
Price
$3.23
Model fair valueConfidence: good
$4.75
Model range
$3.46 to $6.05
Fair value $4.75
Price $3.23
2 models fit Coty Inc. Class A Common Stock and they disagree: 0 of 2 land within 15% of the average. The price is below every model.
Two or more of our models back this value.
Large discount(i)Silver70
Valued as a mature, profitable company: Discounted cash flow and P/E comparison.
ACCE opinionCoty Inc. Class A Common Stock (COTY)
Fair value (2 models)
$4.75
ACCE price target
$2.90
Rating
Undervalued
Horizon
12 months
Fair value published on 21 Oct 2026, 12:04 CEST; previously $4.89 since 16 Oct 2026, 00:00 CEST.
ACCE price target published on 11 Oct 2026, 00:00 CEST.
Rating published on 21 Oct 2026, 12:04 CEST.
Price used: $3.23 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow and P/E comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
32.0% below
+47.2% to fair value
ACCE score
47
out of 100
Analysts
0% buy
17 covering
P/E
0.0x
forward 9.0x
1-year return
-21.6%
Dividend yield
0.00%

Coty Inc. Class A Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Coty sells fragrances (Burberry, Gucci and Calvin Klein licences among them), colour cosmetics such as CoverGirl and Rimmel, and skin and hair care, with the bulk of revenue coming from prestige and mass fragrance. Its case rests on a 62.9% gross margin, which says the brands still command pricing, and on a forward P/E of 7.9 against a trailing P/E of zero, a gap that reflects a loss-making year rather than a cheap earnings base. Revenue growth of 1.3% and a -2.4% operating margin mean the thesis depends on cost actions and portfolio simplification, including the disposal of non-core brands and the reduction of debt, converting into operating profit. The stock is interesting now only as a turnaround test: the valuation looks undemanding if management delivers margin recovery, but the -16.1% return on equity and the absence of index membership show the market has not yet been persuaded, so this merits a deeper look at the balance sheet and the cadence of margin repair before any position is considered.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
  • high
    Negative operating and net margins
    Operating margin is -2.4% and net margin -10.4%, with ROE at -16.1%. Earnings fell 22.2% year over year, so the business is currently losing money at the bottom line.
  • moderate
    Leverage with thin equity
    Debt/Equity of 1.10 is high for a company with negative returns on equity, leaving less cushion if revenue growth of 1.3% stalls further.
  • moderate
    Elevated short interest
    Short interest stands at 10.8% of float, indicating meaningful bearish positioning that could amplify volatility around earnings or news.

AI research notes

AI-assisted·How I use AIWritten Oct 14, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Free cash flow over the last twelve months reached $348M, and the stock's free cash flow yield is 13.6%.
  • Revenue has grown 4.6% a year on average over five years, so the business has expanded over time.
  • At a forward P/E of 7.9x, the shares are priced low relative to expected earnings.
Why it could disappoint
  • The company is losing money, with a net margin of -10.4% and a return on equity of -16.1%.
  • Not one of 17 analysts rates the stock Buy or Strong Buy, and their mean price target of $2.64 sits below the $2.95 share price.
  • Debt is high at 1.10 times equity, and the latest quarter missed earnings expectations by -100.0%.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Nov 4, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where COTY's valuation models land
Price
$3.23
Model fair value
$4.75
Model range
$3.46 to $6.05
Fair value $4.75
Price $3.23
The price is below the whole model range.
Model
Fair value
Upside
Discounted cash flow
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bearish0% buy · 17 covering analysts
● Strong buy 0● Buy 0● Hold 15● Sell 2● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
+0.9%
1 month
+22.3%
3 months
+21.9%
6 months
+33.5%
YTD
+4.9%
1 year
-21.6%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
21 Oct 2026, 12:04 CESTFair value$4.75$4.89$3.22
21 Oct 2026, 12:04 CESTRatingUndervaluedfirst publication$3.22
16 Oct 2026, 00:00 CESTFair value$4.89$4.55$2.94
11 Oct 2026, 00:00 CESTACCE price target$2.90first publication$2.85
1 Oct 2026, 00:00 CESTFair value$4.55$4.89$2.69
28 Sept 2026, 00:00 CESTFair value$4.89$4.59$2.65
24 Sept 2026, 00:00 CESTFair value$4.59$4.52$2.67
19 Sept 2026, 00:00 CESTFair value$4.52$4.92$2.46
17 Sept 2026, 00:00 CESTFair value$4.92$4.64$2.65
11 Sept 2026, 00:00 CESTFair value$4.64$4.77$2.69

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full COTY page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth19Value64Quality38Momentum67Total47
Valuation
Trailing P/E
0.0x
Forward P/E
9.0x
PEG
0.18
P/B
0.97x
EV / Revenue
1.3x
Book value/sh
$3.40
Enterprise value
$7.6B
Profitability
ROE
-16.1%
FCF yield
12.96%
ROIC
-7.5%
Health and risk
Debt / equity
1.10
Dividend yield
0.00%
Beta
0.90

Price

-22.0% · 1Y

Ask anything about COTY

Answered from Coty Inc. Class A Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 100% of peers
low 0.0x0.0xhigh 327.1x
ROEbetter than 0% of peers
low -16%-16%high 19%
Div yieldbetter than 0% of peers
low 0.0%0.0%high 4.9%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
COTY Coty Inc. Class A Common Stock$3.23$532% below--16.1%3847
4912.T Lion Corporation¥1831.00--17.7x9.7%6770
ITP.PA Interparfums SA€34.50€2445% above25.8x17.1%8359
4967.T Kobayashi Pharmaceutical Co., Ltd.¥7150.00--327.1x0.8%4647
NWL Newell Brands Inc. Common Stock$5.73----8.6%3459
IPAR Interparfums Inc. Common Stock$116.07$9621% above22.0x19.1%7762
4527.T Rohto Pharmaceutical Co.,Ltd.¥2851.50--20.0x10.9%6766

Sector report card

Where COTY ranks against its sector peers on each metric.

Computing percentiles…
  • Business Wire•Oct 15, 2026
    Coty Launches Global Fragrance Club, a New Community for the Voices Shaping the Future of Fragrance
  • Business Wire•Aug 20, 2026
    Coty Announces Filing of Annual Report on Form 10-K for the Fiscal Year Ended June 30, 2026
  • Business Wire•Aug 19, 2026
    Coty Announces Fourth Quarter Fiscal Year 2026 Results
2 more press releases · full archive on Investor+.INVESTOR
37 filings
September 2026
Sep 24
ProxyProxy statementPeriod 2026-06-30
View on SEC →
Sep 11
8-KCurrent reportPeriod 2026-09-09
View on SEC →
August 2026
Aug 20
8-KCurrent reportPeriod 2026-08-16
View on SEC →
34 more filings + AI summaries on Investor+.INVESTOR